27 March 2021: Clinical Research
Use of the Water-Soluble Contrast Medium Gastrografin in Treatment of Adhesive Small Bowel Obstruction in Patients with and Without Chronic Radiation Enteropathy: A Single-Center Retrospective Study
Lili Gu 1BCEF , Feng Zhu 1BDE , Tingbin Xie 1BCD , Dengyu Feng 1BEF , Jianfeng Gong 1BDEG* , Ning Li 2ABEFG*DOI: 10.12659/MSM.930046
Med Sci Monit 2021; 27:e930046
Table 2 Patient characteristics regarding Gastrografin challenge test.
| GG challenge (n=30) | No GG (n=30) | p Value | |
|---|---|---|---|
| Sex ratio (M: F) | 9:21 | 7:23 | 0.45 |
| Mean age (years) | 53.5 | 51.1 | 0.41 |
| Blood tests | |||
| Albumin (g/l) | 37.19±6.01 | 36.61±4.98 | 0.61 |
| White blood cells (/mm) | 4.25±2.14 | 3.98±2.05 | 0.77 |
| Platelet (10/L) | 201.62±52.48 | 239.51±54.11 | 0.25 |
| C-reactive protein (mg/l) | 16.53±29.32 | 13.18±24.15 | 0.49 |
| Body Mass Index (BMI) (Kg/m) | 17.8±2.83 | 18.1±3.22 | 0.25 |
| Abdominal CT-scan | |||
| Junction sign | 14 (46.6) | 22 (73.3) | |
| Peritoneal effusion | 8 (26.6) | 11 (36.6) | 0.31 |
| Abnormal small bowel wall vascularization | 17 (56.6) | 13 (43.3) | 0.41 |
| Mesenteric infiltration | 4 (13.3) | 6 (20.0) | 0.26 |
| Type of previous abdominal surgery | |||
| Appendectomy | 5 (16.6) | 3 (30.0) | 0.89 |
| Gastroduodenal | 2 (6.6) | 1 (3.3) | 0.51 |
| Small bowel | 1 (3.3) | 3 (10.0) | 0.08 |
| Colorectal | 12 (40.0) | 11 (36.6) | 0.81 |
| Trauma exploration | |||
| Cholecystectomy | 1 (3.3) | 3 (10.0) | 0.33 |
| Gynecologic surgery | 4 (13.3) | 3 (10.0) | 0.51 |
| Adhesolysis | 6 (20.0) | 10 (33.3) | |
| Duration of symptoms before admission (hours) | 28.8±7.8 | 30.1±8.7 | 0.67 |